183 related articles for article (PubMed ID: 34051685)
21. Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.
Ozturk K; Soylu E; Cayci Z
Neuroradiology; 2021 Nov; 63(11):1801-1810. PubMed ID: 33738509
[TBL] [Abstract][Full Text] [Related]
22. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
Suh HB; Choi YS; Bae S; Ahn SS; Chang JH; Kang SG; Kim EH; Kim SH; Lee SK
Eur Radiol; 2018 Sep; 28(9):3832-3839. PubMed ID: 29626238
[TBL] [Abstract][Full Text] [Related]
23. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
[TBL] [Abstract][Full Text] [Related]
24. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
Wang P; Shi YH; Li JY; Zhang CZ
World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging.
Hung ND; Anh NN; Minh ND; Huyen DK; Duc NM
Biomed Rep; 2023 Nov; 19(5):82. PubMed ID: 37881606
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.
Lin X; Lee M; Buck O; Woo KM; Zhang Z; Hatzoglou V; Omuro A; Arevalo-Perez J; Thomas AA; Huse J; Peck K; Holodny AI; Young RJ
AJNR Am J Neuroradiol; 2017 Mar; 38(3):485-491. PubMed ID: 27932505
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Kitamura Y; Mizoguchi M; Yoshimoto K; Kuga D; Suzuki SO; Baba S; Isoda T; Iwaki T; Iihara K; Honda H
J Magn Reson Imaging; 2016 Nov; 44(5):1256-1261. PubMed ID: 27093558
[TBL] [Abstract][Full Text] [Related]
29. Differentiating primary central nervous system lymphoma from glioblastoma by time-dependent diffusion using oscillating gradient.
Kamimura K; Nakano T; Hasegawa T; Nakajo M; Yamada C; Kamimura Y; Akune K; Ejima F; Ayukawa T; Nagano H; Takumi K; Nakajo M; Higa N; Yonezawa H; Hanaya R; Kirishima M; Tanimoto A; Iwanaga T; Imai H; Feiweier T; Yoshiura T
Cancer Imaging; 2023 Nov; 23(1):114. PubMed ID: 38037172
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of
Norikane T; Mitamura K; Yamamoto Y; Manabe Y; Murao M; Arai-Okuda H; Hatakeyama T; Miyake K; Nishiyama Y
J Neurooncol; 2024 Jan; 166(1):195-201. PubMed ID: 38160415
[TBL] [Abstract][Full Text] [Related]
31. Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.
Togao O; Chikui T; Tokumori K; Kami Y; Kikuchi K; Momosaka D; Kikuchi Y; Kuga D; Hata N; Mizoguchi M; Iihara K; Hiwatashi A
PLoS One; 2020; 15(12):e0243839. PubMed ID: 33315914
[TBL] [Abstract][Full Text] [Related]
32. MR Imaging-Based Analysis of Glioblastoma Multiforme: Estimation of IDH1 Mutation Status.
Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Hatae R; Yoshimoto K; Mizoguchi M; Suzuki SO; Yoshiura T; Honda H
AJNR Am J Neuroradiol; 2016 Jan; 37(1):58-65. PubMed ID: 26405082
[TBL] [Abstract][Full Text] [Related]
33. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
Yamashita K; Yoshiura T; Hiwatashi A; Togao O; Yoshimoto K; Suzuki SO; Abe K; Kikuchi K; Maruoka Y; Mizoguchi M; Iwaki T; Honda H
Neuroradiology; 2013 Feb; 55(2):135-43. PubMed ID: 22961074
[TBL] [Abstract][Full Text] [Related]
34. Dynamic Contrast-Enhanced T1-Weighted Perfusion Magnetic Resonance Imaging Identifies Glioblastoma Immunohistochemical Biomarkers via Tumoral and Peritumoral Approach: A Pilot Study.
Ozturk K; Soylu E; Tolunay S; Narter S; Hakyemez B
World Neurosurg; 2019 Aug; 128():e195-e208. PubMed ID: 31003026
[TBL] [Abstract][Full Text] [Related]
35. Integrative analysis of diffusion-weighted MRI and genomic data to inform treatment of glioblastoma.
Jajamovich GH; Valiathan CR; Cristescu R; Somayajula S
J Neurooncol; 2016 Sep; 129(2):289-300. PubMed ID: 27393347
[TBL] [Abstract][Full Text] [Related]
36. Diffusion radiomics as a diagnostic model for atypical manifestation of primary central nervous system lymphoma: development and multicenter external validation.
Kang D; Park JE; Kim YH; Kim JH; Oh JY; Kim J; Kim Y; Kim ST; Kim HS
Neuro Oncol; 2018 Aug; 20(9):1251-1261. PubMed ID: 29438500
[TBL] [Abstract][Full Text] [Related]
37. Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas.
Su CQ; Lu SS; Zhou MD; Shen H; Shi HB; Hong XN
Clin Radiol; 2019 Feb; 74(2):154-160. PubMed ID: 30391048
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility-weighted imaging provides complementary value to diffusion-weighted imaging in the differentiation between pyogenic brain abscesses, necrotic glioblastomas, and necrotic metastatic brain tumors.
Lai PH; Chung HW; Chang HC; Fu JH; Wang PC; Hsu SH; Hsu SS; Lin HS; Chuang TC
Eur J Radiol; 2019 Aug; 117():56-61. PubMed ID: 31307653
[TBL] [Abstract][Full Text] [Related]
39. IDH1 mutation prediction using MR-based radiomics in glioblastoma: comparison between manual and fully automated deep learning-based approach of tumor segmentation.
Choi Y; Nam Y; Lee YS; Kim J; Ahn KJ; Jang J; Shin NY; Kim BS; Jeon SS
Eur J Radiol; 2020 Jul; 128():109031. PubMed ID: 32417712
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging.
Radbruch A; Wiestler B; Kramp L; Lutz K; Bäumer P; Weiler M; Roethke M; Sahm F; Schlemmer HP; Wick W; Heiland S; Bendszus M
Eur J Radiol; 2013 Mar; 82(3):552-6. PubMed ID: 23238364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
